MDManfred Dahm

Manfred Dahm

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manfred Dahm has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Solitary fibrous tumor of the lung: diagnostic challenges and surgical management

    by Vasileios Leivaditis, Konstantinos Grapatsas, Francesk Mulita, Sofoklis Mitsos, Efstratios Koletsis, Athanasios Papatriantafyllou, Elias Liolis, Admir Mulita, Periklis Tomos, Manfred Dahm

    Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that typically arise from the pleura but may occur in various extrathoracic sites. Primary intraparenchymal pulmonary SFTs without pleural attachment are exceptionally uncommon and often pose diagnostic and therapeutic challenges. We report the case of a middle-aged female patient presenting with progressive dyspnea and a large mass in the left lower lobe on imaging. Computed tomography revealed a well-circumscribed, hypervascular mass occupying the left lower lobe. Bronchoscopic and percutaneous biopsies were nondiagnostic, and surgical resection was pursued. Intraoperatively, the tumor was found to arise from the lung parenchyma without pleural involvement. Histopathological examination demonstrated a spindle-cell neoplasm with the typical “patternless pattern,” and immunohistochemistry confirmed nuclear STAT6 positivity, establishing the diagnosis of SFT. The postoperative course was uneventful apart from a transient pulmonary embolism, which was successfully treated. The patient was discharged in good condition and is under regular radiologic surveillance. SFTs of the lung are rare and often mimic more common pulmonary tumors radiologically. Histologic confirmation with STAT6 immunohistochemistry is crucial for accurate diagnosis. Complete surgical excision remains the mainstay of treatment. Given the risk of late recurrence—especially in large tumors—long-term imaging follow-up is mandatory. This case highlights the importance of considering SFT in the differential diagnosis of large pulmonary masses, the critical role of STAT6-based histopathologic confirmation, and the necessity for prolonged surveillance even after complete resection.


  • Massive right intrathoracic liver herniation four years after traumatic diaphragmatic rupture

    by Vasileios Leivaditis, Athanasios Papatriantafyllou, Benjamin Ehle, Michail Galanis, Efstratios Koletsis, Francesk Mulita, Manfred Dahm, Vasileios Lozos, Konstantinos Grapatsas

    Diaphragmatic hernias following severe thoracoabdominal injuries are infrequent clinical occurrences, and right-sided post-traumatic hernias are particularly rare due to the protective barrier provided by the liver. The overall incidence of diaphragmatic rupture following trauma is approximately 1.3%, with only 20% of these cases identified on the right side. This report aims to present the case of a patient diagnosed with a substantial intrathoracic liver hernia 4 years after a traumatic incident. Surgical intervention successfully corrected the diaphragmatic defect, and the patient’s postoperative course was uneventful. A 2-month follow-up revealed no signs of recurrence, underscoring the effectiveness of the surgical approach in managing this unusual presentation of diaphragmatic hernia.

  • Thoracoscopic treatment of recurrent catamenial pneumothorax

    by Vasileios Leivaditis, Athanasios Papatriantafyllou, Konstantinos Grapatsas, Efstratios Koletsis, Nikolaos Charokopos, Francesk Mulita, Ioannis Panagiotopoulos, Manfred Dahm

    Introduction: Catamenial pneumothorax is a rare but potentially life-threatening condition that affects women of reproductive age. It is characterized by the recurrent occurrence of pneumothorax during or around the menstrual period. The pathophysiology of catamenial pneumothorax is not well understood, but is thought to be related to the presence of endometrial tissue in the pleural cavity. Case Presentation: A 42-year-old woman was referred to our outpatient department for further thoracic surgical treatment. She already had two previous episodes of pneumothorax that occurred during her menstrual period. A chest X-ray revealed a right-sided pneumothorax and she was admitted to the hospital where a chest tube was placed to treat the pneumothorax. CT scan revealed the presence of endometrial tissue under the right diaphragm. The patient underwent a total laparoscopic hysterectomy to remove the source of endometrial tissue. The subdiaphragmatic endometrial tissue was also removed. She subsequently underwent thoracoscopic treatment to treat the pneumothorax. Conclusion: The aim of this study was to review the clinical features, diagnostic criteria, and treatment options for catamenial pneumothorax. In addition, the study highlights the importance of a multidisciplinary approach to the management of catamenial pneumothorax, involving pulmonologists, gynecologists, and thoracic surgeons. Further studies are needed to optimize the management of this rare condition.

  • The Dose-Dependent Cardioprotective Effect of Levosimendan against Ischemia/Reperfusion Injury in an Isolated Rat Heart Experimental Model

    by V. Leivaditis, E. Koletsis, K. Grapatsas, D. Dougenis, M. Dahm

    Background: This study aims to investigate the dose-dependent effect of levosimendan in an experimental model of ischemia–reperfusion injury in isolated rat hearts. Method: The Langendorff's isolated heart perfusion model was used. The isolated rat hearts underwent 30 minutes of perfusion, a 30-minute period of regional ischemia, and a 120-minute period of reperfusion. Animals were randomly divided into eight experimental groups of nine animals in each group: (1) control, (2) sham, (3) digox (negative control, digoxin of 1.67 μg/min), (4) levo 1 (levosimendan: 0.01 μg/min), (5) levo 2 (levosimendan: 0.03 μg/mL), (6) levo 3 (levosimendan: 0.1 μg/min), (7) levo 4 (levosimendan: 0.3 μg/min), (8) levo 5 (levosimendan: 1 μg/min). Hemodynamic parameters were recorded throughout the experiment. Occurrence of arrhythmias and coronary flow were also studied. At the end of every experiment, the infarct size was measured and evaluated. Markers of myocardial injury were also recorded. Finally, reactive oxygen species were measured. Results: A dose-dependent improvement of the hemodynamic response was observed after the administration of levosimendan in various concentrations. Levosimendan offered a significant increase of the coronary flow and a reduction of arrhythmias. A dose-dependent reduction of the size of myocardial infarction, myocardial injury was also demonstrated. Conclusion: The administration of levosimendan offers a significant improvement in the hemodynamic response of isolated hearts, an increase of the coronary flow, and a significant reduction of the occurrence of arrhythmias, of the size of myocardial infarction and oxidative stress in isolated rat hearts. Article published online: 28 January 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Ultrathin polymer monolayers for promotion of cell growth on bioprosthetic materials – Evolution of a new concept to improve long term performance of biologic heart vales

    by Manfred Dahm, Jürgen Rühe, Bernd Berchthold, Diethard Prüfer, Oswald Prucker, Bung‐Jun Chang, Anja Wallrath, Hellmut Oelert

    Reoperation of aldehyde tanned bioprotheses due to calcific degeneration remains their major drawback. Based on experiments studying mechanisms and factors that influence the time phase, extent and progression of calcification and evaluating the efficiency of anticalcification treatments and the effects of surface seeding with vital cells a new concept to avoid calcification emerged: masking aldehyde‐residues with a covalently bound polymer that supports surface cell seeding. Different covalently bound polymers were tested for their suitability to grow cells. Dense cell growth was achieved on some polymers but without correlation to physico‐chemical properties. Ultrathin coating of biological materials appears a promising approach to achieve lining with vital cells.


  • Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart

    by Diethard Pruefer, Ute Buerke, Markus Khalil, Manfred Dahm, Harald Darius, Hellmut Oelert, Michael Buerke


  • Comparison of diagnostic performance of cardiac troponin I on the IMMULITE system with other automated troponin I assays in minor myocardial damage

    by G Hafner, D Peetz, H Erbes, F Post, M Dahm, A A Peivandi, B Sucké, S Blankenberg, H J Rupprecht, W Prellwitz

    An analytical and clinical evaluation of cardiac troponin I (cTnI) on the IMMULITE system is presented. The assay results were compared with those of the Stratus II and the Dimension RxL-HM. A between-run imprecision CV < 20% was found at a cTnI concentration of 0.23 microg/L (functional limit of detection). On the basis of a reference study including 215 patients without ischemic heart disease (97.5th percentile: 0.294 microg/L) and 36 patients clinically classified as having stable angina pectoris (<0.22 microg/L) a preliminary cutoff level of 0.3 microg/L was defined. Assay linearity, sample stability, influence of sample material and method comparison studies were performed. In patients with Duchenne's disease, chronic hemodialysis treatment, pulmonary embolism, coronary artery bypass surgery and minimally cardiac surgery the cTnI results of the IMMULITE agreed better with the Dimension RxL-HM than with the Stratus II data. Of 142 samples from patients with unstable angina 67 samples were classified as cTnI positive with the IMMULITE, 76 with the Dimension RxL-HM, and 62 with the Stratus II. In conclusion, the new assay is sensitive for the determination of cTnI and easy to perform within 45 min.